ValuentumAd

Official PayPal Seal














Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jan 7, 2014
In-Line Is Good Enough…for Today
Valeant Pharma issues in-line guidance for 2014, while Cray reiterates outlook. Shares of both companies soar.
Jan 7, 2014
Boeing Sets Records for 2013; Aerospace Thesis Remains Intact
The large airframe maker is setting records as the commercial aerospace cycle continues its upswing.
Jan 6, 2014
Household Durables Firms, Electronics Retailers Face Pressure
Select Comfort warns, and hhgregg’s quarterly sales disappoint.
Jan 5, 2014
Throw December Auto Sales Numbers Away; December Ice Storms and a Late Thanksgiving Holiday to Blame
We’re not reading too much into December auto sales numbers, which weren’t as strong as expected. 2013 was a fantastic year for the automakers, and we think 2014 will be even better.
Jan 4, 2014
Dividend Increases/Decreases for the Two Weeks Ending January 3
Let's take a look at dividend increases/decreases for the two weeks ending January 3.
Jan 3, 2014
Buffett Doubles Down on USG; Teva Expected to Appoint New CEO; Crude by Rail Transportation Comes under Scrutiny
Buffett more than doubles stake in wallboard maker USG, generic pharmaceutical giant Teva rumored to find CEO, while concerns about crude-by-rail heighten.
Jan 2, 2014
Valuentum's January Edition of Its Dividend Growth Newsletter!
The January edition of the Dividend Growth Newsletter is now available.
Jan 2, 2014
Dividend Growth Investors Face Unique Risks in 2014
2013 was fantastic for dividend growth investors, and 2014 may be just as good. However, investors should be aware of the increasing risks that have come with the new year.
Dec 31, 2013
Merger Chatter Heating Up for the New Year
Could New York Times find a suitor and will a Pepsi-Mondelez deal happen? Let’s dig in.
Dec 27, 2013
Quiet Trading This Week
Let’s discuss a few news items during this very quiet week of trading.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.